130 related articles for article (PubMed ID: 8032825)
1. Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma.
Pummer K; PĆ¼rstner P; Auner HL; Stettner H; Trummer H; Penkoff H; Rauchenwald M
Br J Urol; 1994 Jun; 73(6):612-4. PubMed ID: 8032825
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers.
Masuda H; Kurita Y; Suzuki K; Fujita K; Aso Y
Br J Urol; 1997 Jul; 80(1):25-9. PubMed ID: 9240175
[TBL] [Abstract][Full Text] [Related]
3. Serum immunosuppressive acidic protein in renal cell carcinoma.
Ueda T
Urol Res; 1986; 14(2):101-3. PubMed ID: 3727211
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.
Ueda T; Yasumasu T; Uozumi J; Naito S
Br J Urol; 1993 Oct; 72(4):409-12. PubMed ID: 8261296
[TBL] [Abstract][Full Text] [Related]
5. Serum basic fetoprotein in patients with renal cell carcinoma.
Gohji K; Ishii M; Nagata H; Matsumoto O; Kamidono S
Cancer; 1990 Mar; 65(6):1405-11. PubMed ID: 1689608
[TBL] [Abstract][Full Text] [Related]
6. Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma.
Igarashi T; Tobe T; Kuramochi H; Akakura K; Ichikawa T; Hamano S; Suzuki N; Furuya Y; Ito H
Jpn J Clin Oncol; 2001 Jan; 31(1):13-7. PubMed ID: 11256835
[TBL] [Abstract][Full Text] [Related]
7. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
9. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
10. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
12. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
13. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
[TBL] [Abstract][Full Text] [Related]
14. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
[TBL] [Abstract][Full Text] [Related]
15. Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
Fujikawa K; Matsui Y; Miura K; Kobayashi T; Oka H; Fukuzawa S; Takeuchi H
J Urol; 2000 Sep; 164(3 Pt 1):673-5. PubMed ID: 10953123
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Hayashi T; Kanetake H
BJU Int; 2001 Dec; 88(9):974-7. PubMed ID: 11851623
[TBL] [Abstract][Full Text] [Related]
17. Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Morozov AA; Goryacheva IO; Filipenko ML; Alferov AA; Bezhanova SD; Bazaev VV; Kazantseva IA
Bull Exp Biol Med; 2019 Jan; 166(3):353-357. PubMed ID: 30627905
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
Kawata N; Yamaguchi K; Hirakata H; Hachiya T; Yoshida T; Takimoto Y
Urology; 2005 Oct; 66(4):736-40. PubMed ID: 16230127
[TBL] [Abstract][Full Text] [Related]
19. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin: a tumor marker for renal cell carcinoma.
Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]